Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

Comparison of Marketing Authorisation and its Requirements for Singapore and Thailand

The availability of generic medication is an important

issue in the ASEAN regions. The regulatory requirements

of various countries of the world vary from each other.

Therefore, it is challenging for the companies to develop a

single drug which can be simultaneously submitted in all the

countries for approval. The regulatory strategy for product

development has to be established before commencement

of developmental work in order to avoid major surprises

after submission of the application. The JSS College team

with Balamuralidhara V. at the Regulatory Affairs Group,

Department of Pharmaceutics, JSS College of Pharmacy

provides an overview on Singapore and Thailand’s marketing

authorisation.

https://international-pharma.com/wp-content/uploads/2017/04/Comparison-of.pdf
Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025